cancer doctors

Colorectal Cancer Survival

Question: Survival rate recurrent colorectal cancers?

Answer: There are too many variables to give you a direct answer. How extensive was the cancer? Has it recurred in the same site or metasticized? What specific type of cancer was it? How early was it caught each time? If it has spread, where to? Usually removing the rectum and affected parts of the colon gives good long term results. My grandmother's cousin had this kind of cancer when she was about 30 years old and had a colostomy at that time. She passed away last year at age 98. But if the cancer has spread beyond the colon, then there are a lot of other factors involved. You should ask your oncologist, who has a much better idea of what is happening in your specific situation than any of us possibly could.


Colorectal Cancer Survival News

InPharm

Novel Agent Improves Survival in Metastatic Colorectal Cancer
Medscape
 

Drug Improves Survival of Colorectal Cancer Patients, Trial Results Show

MarketWatch (press release)
"This is the first novel agent in eight years to show improvement in overall survival of colon cancer patients who have run out of treatment options." Researchers tested regorafenib in a phase III, randomized, placebo-controlled trial, ...
 

Irish Medical Times

Women have better cancer survival rate than men: Singapore study
Straits Times
 

Regorafenib improved survival, delayed progression in colorectal cancer

HemOncToday
SAN FRANCISCO ? The investigational drug regorafenib extended survival in patients with treatment-refractory metastatic colorectal cancer by 1.4 months, according to data presented at the 2012 ASCO Gastrointestinal Cancers Symposium.
 

Clinical Oncology News

Roche's Avastin helps colorectal cancer patients
Reuters
 

New bowel cancer screening campaign launched

WebMD.Boots.com
Cancer Research UK says bowel cancer is the UK's second biggest cancer killer. Bowel cancer - also known as colorectal cancer - affects 33000 people every year in England. Most cases are over 55s. 13000 people a year die from bowel cancer, but survival ...
 

Balancing oxaliplatin dose with neurological side effects in metastatic colon ...

Medical Xpress
The drug oxaliplatin is a major reason the prognosis for metastatic colon cancer has gone from an expected survival of several months to a couple years. Unfortunately, the drug can also carry with it debilitating neurological side effects, ...
 

immatics Presents Positive Phase II Results With its Therapeutic Cancer ...

MarketWatch (press release)
IMA910 comprises 13 tumor-associated peptides (TUMAPs) identified directly from patients suffering from colorectal cancer. The IMA910 study recruited 92 patients with advanced/metastatic CRC who had shown no progression following 12 weeks of first line ...
 

Signal Genetics Announces Publication of Meta-Analysis of its Colon Cancer ...

MarketWatch (press release)
The data from the paper demonstrate the value of implementing Previstage testing in patients with colorectal cancer to identify those patients at risk of relapse. The paper is the culmination of the work conducted by a team of researchers and ...
 

Anti-VEGFR2 Inhibitor Shows No Clinical Benefit in Colon Cancer

Medscape
Although preliminary clinical trials were promising, this latest international phase 3 trial of 750 patients with chemotherapy-refractive metastatic colorectal cancer indicates that not only does brivanib alaninate fail to improve overall survival when ...
 

Types of Cancer


Adrenal Cancer Anal Cancer Brain Cancer Colorectal Cancer Endometrial Cancer Esophageal Cancer
Esophageal Cancer Laryngeal Cancer Oral Cancer Penile Cancer Prostatic Cancer Stomach Cancer
Thyroid Cancer Bladder Cancer Bone Cancer Cervix Cancer Heart Cancer Kidney Cancer
Melanoma Cancer Pancreas Cancer Asbestos Cancer